Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results from the NODE-303 Open-label Study
J Am Coll Cardiol
.
2024 Mar 18:S0735-1097(24)06670-1.
doi: 10.1016/j.jacc.2024.03.384.
Online ahead of print.
Authors
James E Ip
1
,
Benoit Coutu
2
,
Peter A Noseworthy
3
,
Maria L Parody
4
,
Farhad Rafii
5
,
Samuel F Sears
6
,
Narendra Singh
7
,
Bruce S Stambler
8
,
David B Bharucha
9
,
A John Camm
10
Affiliations
1
Weill Cornell Medical Center, New York Presbyterian Hospital, New York, USA. Electronic address: jei9008@med.cornell.edu.
2
Montreal University Hospital Center, Montreal, Canada.
3
Mayo Clinic, Rochester, USA.
4
Hospital San Roque, San Roque, Argentina.
5
lnterventional Cardiology Medical Group, West Hills, CA, USA.
6
East Carolina University, Psychology and Cardiovascular Sciences, Greenville, USA.
7
NSC Research Center, Johns Creek, USA.
8
Piedmont Heart Institute, Atlanta, USA.
9
Milestone Pharmaceuticals, Charlotte, NC, USA.
10
St George's University of London, London, United Kingdom.
PMID:
38537917
DOI:
10.1016/j.jacc.2024.03.384
No abstract available
Publication types
Letter